Structural and microstructural neuroimaging signature of C9orf72-associated ALS: A multiparametric MRI study

•C9orf72-associated ALS showed distinct white matter alterations and ubiquitous gray matter volume reductions.•DTI in C9orf72 ALS demonstrated alterations in axonal WM structures to the frontal lobes.•DTI and ABV strengthen the hypothesis of a developmental disorder in C9orf72 ALS.•Unbiased MRI anal...

Full description

Saved in:
Bibliographic Details
Published inNeuroImage clinical Vol. 39; p. 103505
Main Authors Wiesenfarth, Maximilian, Huppertz, Hans-Jürgen, Dorst, Johannes, Lulé, Dorothée, Ludolph, Albert C., Müller, Hans-Peter, Kassubek, Jan
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.01.2023
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•C9orf72-associated ALS showed distinct white matter alterations and ubiquitous gray matter volume reductions.•DTI in C9orf72 ALS demonstrated alterations in axonal WM structures to the frontal lobes.•DTI and ABV strengthen the hypothesis of a developmental disorder in C9orf72 ALS.•Unbiased MRI analysis might be an appropriate in vivo biomarker in early C9orf72 ALS. ALS patients with hexanucleotide expansion in C9orf72 are characterized by a specific clinical phenotype, including more aggressive disease course and cognitive decline. Computerized multiparametric MRI with gray matter volumetry and diffusion tensor imaging (DTI) to analyze white matter structural connectivity is a potential in vivo biomarker. The objective of this study was to develop a multiparametric MRI signature in a large cohort of ALS patients with C9orf72 mutations. The aim was to investigate how morphological features of C9orf72-associated ALS differ in structural MRI and DTI compared to healthy controls and ALS patients without C9orf72 mutations. Atlas-based volumetry (ABV) and whole brain-based DTI-based analyses were performed in a cohort of n = 51 ALS patients with C9orf72 mutations and compared with both n = 51 matched healthy controls and n = 51 C9orf72 negative ALS patients, respectively. Subsequently, Spearman correlation analysis of C9orf72 ALS patients‘ data with clinical parameters (age of onset, sex, ALS-FRS-R, progression rate, survival) as well as ECAS and p-NfH in CSF was performed. The whole brain voxel-by-voxel comparison of fractional anisotropy (FA) maps between C9orf72 ALS patients and controls showed significant bilateral alterations in axonal structures of the white matter at group level, primarily along the corticospinal tracts and in fibers projecting to the frontal lobes. For the frontal lobes, these alterations were also significant between C9orf72 positive and C9orf72 negative ALS patients. In ABV, patients with C9orf72 mutations showed lower volumes of the frontal, temporal, and parietal lobe, with the lowest values in the gray matter of the superior frontal and the precentral gyrus, but also in hippocampi and amygdala. Compared to C9orf72 negative ALS, the differences were shown to be significant for cerebral gray matter (p = 0.04), especially in the frontal (p = 0.01) and parietal lobe (p = 0.01), and in the thalamus (p = 0.004). A correlation analysis between ECAS and averaged regional FA values revealed significant correlations between cognitive performance in ECAS and frontal association fibers. Lower FA values in the frontal lobes were associated with worse performance in all cognitive domains measured (language, verbal fluency, executive functions, memory and spatial perception). In addition, there were significant negative correlations between age of onset and atlas-based volumetry results for gray matter. This study demonstrates a distinct pattern of DTI alterations of the white matter and ubiquitous volume reductions of the gray matter early in the disease course of C9orf72-associated ALS. Alterations were closely linked to a more aggressive cognitive phenotype. These results are in line with an expected pTDP43 propagation pattern of cortical affection and thus strengthen the hypothesis that an underlying developmental disorder is present in ALS with C9orf72 expansions. Thus, multiparametric MRI could contribute to the assessment of the disease as an in vivo biomarker even in the early phase of the disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Shared senior authorship.
ISSN:2213-1582
2213-1582
DOI:10.1016/j.nicl.2023.103505